[Federal Register: September 24, 2004 (Volume 69, Number 185)]
[Notices]
[Page 57324]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24se04-76]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-2200-N4]
Medicare Program; Meeting of the State Pharmaceutical Assistance
Transition Commission--October 14, 2004
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting of the State
Pharmaceutical Assistance Transition Commission (SPATC). Notice of this
meeting is given under the Federal Advisory Committee Act (5 U.S.C.
App. 2, section 10(a)(1) and (a)(2)). The SPATC will develop a proposal
for addressing the unique transitional issues facing State
Pharmaceutical Assistance Programs (SPAPs) and SPAP participants due to
the implementation of the voluntary prescription drug benefit program
under Part D of title XVIII of the Social Security Act. This notice
also announces the appointment of an additional member to serve on the
SPATC. This individual is Dennis R. O'Dell, Corporate Vice President,
Health Services, Walgreen CO, Deerfield, IL.
DATES: The Meeting: October 14, 2004, 9 a.m. to 5 p.m. e.d.s.t.
Deadline for Comments: October 6, 2004.
Special Accommodations: Persons attending the meeting who are
hearing or visually impaired, or have a condition that requires special
assistance or accommodations, are asked to notify the Executive
Secretary by October 6, 2004 (see FOR FURTHER INFORMATION CONTACT.)
ADDRESSES:
The Meeting: The meeting will be held at the following address:
Holiday Inn, WASHINGTON-ON THE HILL, 415 New Jersey Avenue, NW.,
Washington, DC 20001, United States, Toll-Free 1-800-638-1116,
Telephone: 1-202-638-1616, Fax: 1-202-638-0707.
Comments: Submit written comments to Marge Watchorn, Executive
Secretary, Center for Medicaid and State Operations, Centers for
Medicare & Medicaid Services, 7500 Security Boulevard, Mail Stop S2-01-
16, Baltimore, MD 21244.
Registration: Registration for members of the public is optional
for this meeting. If you choose to register, please go to http://www.cms.hhs.gov/events/
and follow the instructions on the Web site.
Web site: You may access up-to-date information on this meeting at
http://www.cms.hhs.gov/faca/spatc/details.asp.
Hotline: You may also access up-to-date information on this meeting
on the CMS Advisory Committee Information Hotline, 1-877-449-5659 (toll
free) or in the Baltimore area (410) 786-9379.
FOR FURTHER INFORMATION CONTACT: Marge Watchorn, Executive Secretary,
410-786-4361. Mary Kahn, Press Inquiries, 202-690-6145.
SUPPLEMENTARY INFORMATION: On February 27, 2004, we published a notice
(69 FR 9326) requesting nominations for individuals to serve on the
State Pharmaceutical Assistance Transition Commission (SPATC). On March
5, 2004, we published a notice (69 FR 10455) announcing the
establishment of the SPATC and the signing by the Secretary on March 1,
2004 of the charter establishing the SPATC. On June 18, 2004, we
published a notice (69 FR 34169) announcing the first meeting of the
SPATC, held on July 7, 2004, and the appointment of 23 individuals to
serve as members of the SPATC. This notice announces the second public
meeting of the SPATC. This notice also announces the appointment of an
additional individual who will serve on the SPATC. This individual is
Dennis O'Dell, Corporate Vice President, Health Services, Walgreen CO,
Deerfield, IL.
SPATC Members: Joan Henneberry (Chairperson), Clifford Barnes,
Donna Boswell, James Chase, David Clark, Jay Currie, Barbara Edwards,
Nora Dowd Eisenhower, Janice Faiks, Karen Greenrose, Dr. Dewey Garner,
Laurie Hines, Mary Liveratti, Dr. Anne Marie Murphy, Julie Naglieri,
Dennis O'Dell, Robert Power, Susan Reinhard, Sybil Richard, Elizabeth
Rohn-Nelson, Marc Ryan, Linda Schofield, and Martin Schuh.
Topics of the Meeting: The Commission was chartered to address the
transitional issues facing SPAPs and SPAP participants due to the
implementation of the voluntary prescription drug benefit program under
Part D of title XVIII of the Act. The Commission will present findings
from research conducted since the last public meeting held on July 7,
2004.
Procedure and Agenda: This meeting is open to the public.
Registration for members of the public is optional. However, advance
registration will ensure that we are able to accommodate all members of
the public. If you choose to register, please go to the website listed
under ADDRESSES above.
The Commission will spend the majority of the meeting presenting
their findings as a result of research and deliberations regarding the
transitional issues facings SPAPs. After the Commission presents its
findings, members of the public will have an opportunity to address the
Commission regarding these issues.
Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).
(Catalog of Federal Domestic Assistance Program No. 93.774,
Medicare--Supplementary Medical Insurance Program)
Dated: September 10, 2004.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 04-21195 Filed 9-23-04; 8:45 am]
BILLING CODE 4120-01-P